Tymothi Claude, PA
Medical · Litchfield Park, AZNPI 1841718822
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.5% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $603, 2.2 times the $278 reported in 2021.
Across 91 payments — averaging $18.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$373
- E.r. Squibb & Sons, L.L.C.$198
- Sanofi$156
- Novartis$121
- Mayne Pharma Commercial LLC$115
- Amgen$112
- plus $640 from 15 others
What the payments were for
- Food & beverage$1,61994%
- Education$956%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $373 |
| E.r. Squibb & Sons, L.L.C. | 8 | $198 |
| Sanofi | 7 | $156 |
| Novartis | 6 | $121 |
| Mayne Pharma Commercial LLC | 13 | $115 |
| Amgen | 5 | $112 |
| Lilly USA, LLC | 5 | $101 |
| Galderma Laboratories, L.p. | 3 | $87 |
| Johnson & Johnson | 4 | $84 |
| UCB, Inc. | 3 | $58 |
| Boston Scientific | 2 | $49 |
| Organon | 4 | $44 |
| Incyte Corporation | 2 | $38 |
| Organogenesis Inc. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Pfizer | 1 | $27 |
| Arcutis Biotherapeutics, Inc. | 1 | $23 |
| Surgenex LLC | 1 | $22 |
| Phadia US Inc. | 1 | $17 |
| Merck | 1 | $16 |
| Kyowa Kirin, Inc. | 1 | $13 |
How this compares
$1,714 in reported general payments places this provider in the 70th percentile of 748 medical providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 11 | $107,552 |
| Clobetasol Propionate | 87 | $5,126 |
| Metronidazole | 20 | $2,731 |
| Fluorouracil | 34 | $2,082 |
| Doxycycline Hyclate | 40 | $1,792 |
| Ketoconazole | 65 | $1,003 |
| Desonide | 14 | $916 |
| Imiquimod | 22 | $588 |
| Clindamycin Phosphate | 17 | $495 |
| Triamcinolone Acetonide | 58 | $359 |
| Mupirocin | 31 | $268 |
| Minoxidil | 11 | $68 |
Paid to pharmacies, not to this prescriber.
Other medical in Litchfield Park
- Robert CasquejoScottsdale$474K
- Andrew HicksPeoria$460K
- Darren WestScottsdale$206K
- Linda MoorsTucson$122K
- Jamie WystrachScottsdale$79K
- Scott YoungPhoenix$69K
- Scott LightfootPhoenix$61K
- Jennifer KiserPhoenix$53K
- Lakeisha ColterPhoenix$48K
- Amy IngersollPhoenix$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.